Initial evaluation in the climacteric

Luiz Francisco Baccaro, Lúcia Costa‐Paiva, Elizabeth Jeha Nasser, Ana Lúcia Ribeiro Valadares, Célia Regina da Silva, Eliana Aguiar Petri Nahás, Jaime Kulak, M. Rodrigues, Marco Aurélio Albernaz, Maria Celeste Osório Wender, Maria Célia Mendes, Rita de Cássia de Maio Dardes, Rodolfo Strufaldi, Rogerio Cesar Bocardo, Luciano de Melo Pompei
In: Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics · 2022 · vol. 44(05) , pp. 548–556 · doi:10.1055/s-0042-1750282 · PMID:35697068 · W4282831366
article OA: diamond CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-10 ⓘ

This paper discusses the clinical diagnosis and comprehensive evaluation of climacteric syndrome, emphasizing rational complementary exams and judicious use of hormone therapy for aging women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-10 ⓘ

This FEBRASGO position statement reviews evidence and proposes an approach to initial evaluation of women in the climacteric, focusing on how to diagnose menopause and climacteric syndrome, perform opportunistic screening for chronic diseases and neoplasms, and tailor complementary tests for those considering menopausal hormone therapy. It recommends clinical diagnosis for women over 45 with symptoms of hypoestrogenism, defines menopause retrospectively after 12 months of amenorrhea (with optional FSH testing when diagnosis is uncertain), and calls for judicious use of pelvic/transvaginal ultrasound primarily for symptomatic patients such as those with abnormal uterine bleeding. A key caveat is that complementary testing should not be ordered without a clear diagnostic and therapeutic plan. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Climacteric syndrome is a set of signs and symptoms resulting from the interaction between sociocultural, psychological and endocrine factors occurring in aging women. Its diagnosis is clinical in women with the expected age group for ovarian hypofunction. The term "menopause" refers to the date of the woman's last menstrual bleeding episode and is defined retrospectively. Women in menopausal transition have disease prevention and health promotion needs. Hypoestrogenism associated with aging and metabolic syndrome can lead to lower quality of life and increased occurrence of cardiovascular disease. The medical consultation of climacteric women is an excellent opportunity of screening for chronic diseases and neoplasms. Complementary evaluation for climacteric women must be carried out judiciously. The benefit and risk of each test must be considered. Complementary tests without a specific definition of a diagnostic and therapeutic plan should be avoided. Menopausal hormone therapy (HT) may be indicated to treat climacteric symptoms. Detailed clinical history and rational complementary exams are essential to define the therapeutic plan and follow-up of women undergoing HT.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (29)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK